40 results
424B3
PTPI
Petros Pharmaceuticals Inc
23 Nov 21
Prospectus supplement
4:11pm
the writing or settlement of options or other hedging transactions, whether through an options exchange or otherwise;
a combination of any … or interests therein, the selling stockholders may enter into hedging transactions with broker-dealers or other financial institutions, which may
424B3
PTPI
Petros Pharmaceuticals Inc
20 Dec 21
Prospectus supplement
7:24am
a specified number of such securities at a stipulated price per security;
through the writing or settlement of options or other hedging transactions … in compliance with FINRA Rule 2121.
In connection with the sale of the securities or interests therein, the selling stockholders may enter into hedging
S-1
PTPI
Petros Pharmaceuticals Inc
12 Nov 21
IPO registration
5:03pm
number of such securities at a stipulated price per security;
through the writing or settlement of options or other hedging transactions, whether through … with FINRA Rule 2121.
In connection with the sale of the securities or interests therein, the selling stockholders may enter into hedging transactions
8-K
EX-10.1
PTPI
Petros Pharmaceuticals Inc
27 Dec 21
Petros Pharmaceuticals Announces $7.5 Million Offering
5:02pm
“derivative” transaction. The Company further understands and acknowledges that (y) one or more Purchasers may engage in hedging activities at various … deliverable with respect to Securities are being determined, and (z) such hedging activities (if any) could reduce the value of the existing stockholders
8-K
EX-10.1
PTPI
Petros Pharmaceuticals Inc
1 Dec 21
Petros Pharmaceuticals Announces $10 Million Offering
5:12pm
“derivative” transaction. The Company further understands and acknowledges that (y) one or more Purchasers may engage in hedging activities at various times … deliverable with respect to Securities are being determined, and (z) such hedging activities (if any) could reduce the value of the existing stockholders
8-K
EX-10.1
ea71tn08nrye sxbqf
15 Oct 21
Petros Pharmaceuticals Announces $5.7 Million Registered Direct Offering
5:03pm
POS AM
jc8ip8q be
14 Oct 22
Prospectus update (post-effective amendment)
4:05pm
424B3
xeldgn2d
19 Sep 23
Prospectus supplement
4:36pm
8-K
EX-10.1
0d6lyg9c 0vgl5w8j
13 Jul 23
Petros Pharmaceuticals Announces Capital Raise of $15 million
4:41pm
8-K
EX-10.2
2uti99kx
13 Jul 23
Petros Pharmaceuticals Announces Capital Raise of $15 million
4:41pm
8-K/A
EX-99.1
ivy7 ubduaj
31 Dec 20
Metuchen’s Management’s Discussion and Analysis of Financial Condition and Results of Operations
5:00pm
PRE 14A
s42yy99h9kzym1fita
30 Sep 22
Preliminary proxy
4:45pm
DEF 14A
pvk0ecu lu
22 Nov 21
Definitive proxy
4:37pm